share_log
Moomoo 24/7 ·  Mar 11 09:01
TransCode Therapeutics and Akribion Genomics Report Proof-Of-Concept Laboratory Studies In Human Cells; Say Studies To Date 'Suggest That Akribion's G-dase E Ribonucleoprotein Complexes Could Be Conjugated to TransCode's TTX Delivery Platform, Suggesting That the Drug Candidate Could Be Formulated as Intended.'
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment